Pembrolizumab vs Zolpidem

## Pembrolizumab vs Zolpidem: Overview

This comparison examines the pharmacological differences between **Pembrolizumab** and **Zolpidem**.

## Mechanism of Action

**Pembrolizumab**: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

**Zolpidem**: Selective GABA-A receptor alpha-1 subunit agonist.

## Pharmacokinetics

**Half-life**: Pembrolizumab — 26 days; Zolpidem — 2.5 hours.

## Chemical Properties

**Molecular Formula**: Pembrolizumab — N/A; Zolpidem — C19H21N3O.

**Molecular Weight**: Pembrolizumab — N/A; Zolpidem — 307.3950 g/mol.

**Type**: Pembrolizumab — Antibody; Zolpidem — Small molecule.